AstraZeneca (AZN) is set to acquire clinical-stage biopharmaceutical company, Gracell, for a total deal value of up to $1.2 billion.…
Wie der Konzern mitteilte, wird Gracell Biotechnologies für einen Gesamtwert von 1,2 Milliarden US-Dollar übernommen. Der Baranteil liege bei der…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…
Wie der Konzern mitteilte, wird Gracell Biotechnologies für einen Gesamtwert von 1,2 Milliarden US-Dollar übernommen. Der Baranteil liege bei der…
…
…
…
…
Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases…
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Injection Pen Market: Analysis By Type, By Therapy, By…
22 December 2023
Wainua (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated…
Ionis Pharmaceuticals and AstraZenecas Wainua has been approved by the U.S. Food and Drug Administration for treating a symptom of…
FDA approves AstraZeneca (AZN) and Ionis (IONS) Wainua (eplontersen) for ATTRv-PN and gives CRL to Mercks chronic cough candidate, gefapixant.…
FDA approves Ionis (IONS) and partner AstraZenecas (AZN) Wainua for treating ATTRv-PN. Ionis stock rises on this important milestone.…
Dublin, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The "Biologics Drug Discovery Market - A Global and Regional Analysis,…
For investors, the focus in 2024 will be on navigating a year expected to be split into distinct halves. That,…
Assemblin has been commissioned to perform and coordinate multidisciplinary technical installations in the areas of electricity, ventilation, cooling and heating…
Pfizer (PFE) issues a disappointing outlook for 2024. AstraZeneca (AZN) announces that it is buying vaccine company, Icosavax.…
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2024" has been added…
Nacka, Sweden, December 14, 2023: Atlas Copco Group has appointed Christina Malmberg Hägerstrand as its new Media Relations Manager.
Christina Malmberg…
Adobe, AstraZeneca, Intel, Morgan Stanley and EOG Resources are part of the Zacks top Analyst Blog.…
…
Der Pharmakonzern AstraZeneca erweitert Produktportfolio durch den Zukauf von Icosavax für einen Milliardenbetrag. Hannover Rück hebt die Wachstumsziele für die…
Für bis zu 1,1 Milliarden US-Dollar übernimmt AstraZeneca das US-Biopharma-Unternehmen Icosavax. Damit will Astrazeneca seine Impfstoff- und Immuntherapien-Pipeline ...…
The gastroesophageal reflux disease market is expected to show positive growth, mainly attributed to increased prevalence and the expected launch…
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Astrazeneca mit einem Kursziel von 13000 Pence auf "Buy" belassen. Mit…
Vaccines specialist Icosavax Inc (NASDAQ: ICVX) is set to surge 45% on Tuesday after agreeing to be taken over by Anglo-Swedish…
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Astrazeneca mit einem Kursziel von 13000 Pence auf "Buy" belassen. Mit…
In a bid to strengthen its respiratory syncytial virus (RSV) vaccine portfolio, AstraZeneca (NASDAQ:AZN) has agreed to acquire U.S. vaccine…
…
…
AstraZeneca to buy U.S.-based Icosavax for up to $1.1 billion…
…
News Release
Regulatory News Service
12 December 2023
AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase…
Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca…
The company has secured multiple new agreements since it bought AstraZenecas 580,000-square-foot West Chester facility.…
AstraZeneca (AZN) is set to acquire clinical-stage biopharmaceutical company, Icosavax, for a total deal value of up to $1.1 billion.…
…
Itll take a few years for its latest moves to pay off, assuming they do.…
In our Newsletter published on 7TH December 2023, a section was included related to AstraZeneca BioVentureHub. This was not officially…
By John Vandermosten, CFA
NASDAQ:ALLR
Early Results - Phase II Stenoparib
Allarity Therapeutics, Inc. (NASDAQ:ALLR) provided an update to investors on its…
The Global Artificial Intelligence In Precision Medicine Market Size was valued at USD 1.28 Billion in 2022 and the Global…
AstraZeneca PLC (LSE:AZN), the Anglo-Swedish pharmaceutical giant, stands as a quintessential example of a growth at a reasonable price (GARP)…
JP Morgan has identified its top picks in the European pharmaceuticals and biotechnology sector for 2024, spotlighting large, mid, and…
JP Morgan has identified its top picks in the European pharmaceuticals and biotechnology sector for 2024, spotlighting large, mid, and…
…
The Global Melanoma Therapeutics Market Size was valued at USD 5.03 Billion in 2022 and the Worldwide Melanoma Therapeutics Market…
Absci (ABSI) announces a collaboration agreement with AstraZeneca to develop an AI-designed antibody for an undisclosed oncology target. The stock…
…
1 December 2023 15:00 GMT
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…